A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis

Clinical trial NCT04069260 · TERMINATED

Trial details

NCT number: NCT04069260
Sponsor: Eloxx Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Genetic Disease Nonsense Mutation Cystinosis

Start date: 2019-08-02
Primary completion: 2019-12-17
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.